Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence.
about
A novel knowledge representation framework for the statistical validation of quantitative imaging biomarkersLung cancer-a fractal viewpoint.Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agentVolumes to learn: advancing therapeutics with innovative computed tomography image data analysis.A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma.Revisiting the relationship between tumour volume and diameter in advanced NSCLC patients: An exercise to maximize the utility of each measure to assess response to therapyTumor volume as an alternative response measurement for imatinib treated GIST patients.Clinical trials in the era of personalized oncology.Anatomy packing with hierarchical segments: an algorithm for segmentation of pulmonary nodules in CT imagesAssessing the effect of CT slice interval on unidimensional, bidimensional and volumetric measurements of solid tumoursVolumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or GefitinibPhotodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancerVolume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control studySegmentation of lung lesions on CT scans using watershed, active contours, and Markov random field.Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess SarcopeniaTumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI.Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond RECIST progressionOverview: progression-free survival as an endpoint in clinical trials with solid tumors.Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome.Uncertainties in RECIST as a measure of volume for lung nodules and liver tumors.Changes of lung tumour volume on CT - prediction of the reliability of assessments.Statistical analysis of lung nodule volume measurements with CT in a large-scale phantom study.Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer.X-ray computed tomography: semiautomated volumetric analysis of late-stage lung tumors as a basis for response assessments.Survival analyses in lung cancer.Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors.Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib.Volumetric evaluation of hepatic tumors: multi-vendor, multi-reader liver phantom study.
P2860
Q26825076-0E28CFC7-EB22-4E04-BEE6-D0FCCA9B5912Q27310294-339A8EAC-499F-4D9B-9EDD-B70DEEC89156Q28730801-048BCC97-1A18-405C-8166-805F9EC5BDF5Q33636321-A7951DEA-5F91-4F32-A321-E6E460247915Q33779308-65CCE3A1-A341-4C09-AAB2-324CC17260CAQ33929944-AEA8565E-8A31-489D-8B8C-57ED72F03CC3Q34469701-A31D726F-4FBE-48B0-A168-FC9823F2B5E8Q35555963-A2E292BB-F9DE-4882-A3A1-1239A5966806Q35604277-9770FB32-E5F0-4E65-B114-7B2B9BDEA996Q36361598-5EE0CFE0-31AD-4481-B9F1-55EB752749E7Q36553854-5C6AA11A-A886-4B07-B476-3A7992532CC5Q36578574-2D48EFCA-BF3E-4817-8C59-2C7FFA8B3BDDQ36694617-C1124E62-40FB-4ADE-BFB6-598A3BA8C61CQ36744426-708AC9F7-8934-403A-841D-3E87D619275FQ36833793-5C0C7E05-D4CF-4E91-94CD-F5B7D85A8939Q37021940-838E3DF5-0A3D-4BD8-978A-749941E38F8EQ37280018-EEB5EF35-E556-4CB6-BDB7-D96EEABC5424Q38106563-1B36FCCF-096A-4258-B08F-40F28B875D28Q38777057-2E8D7337-3408-4B29-AC11-2469F420AB21Q39621244-CAF634BF-C4C2-4093-8886-593BDB5FCC04Q40370205-C60113A9-A1B8-4A4C-9F9B-A6C3CB2E82ACQ40777241-345416A5-820E-4CBD-8328-FF30FDFC5669Q41206799-415E478B-3F47-4204-947E-11BF4F90D9D5Q41816122-3BC39DBC-F286-4FF4-822B-E80B1CA87435Q42344282-06613739-C812-47B3-B447-65EB93B6D445Q45349782-C137DEFA-6FD4-49E8-B2E0-65A797DF3DAAQ50898344-1AA9B72C-1555-4C84-A133-D725359C98A2Q53080830-B61FA89E-5EA9-4F05-8761-C70C627CB00C
P2860
Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Change in lung tumor volume as ...... itical review of the evidence.
@en
Change in lung tumor volume as ...... itical review of the evidence.
@nl
type
label
Change in lung tumor volume as ...... itical review of the evidence.
@en
Change in lung tumor volume as ...... itical review of the evidence.
@nl
prefLabel
Change in lung tumor volume as ...... itical review of the evidence.
@en
Change in lung tumor volume as ...... itical review of the evidence.
@nl
P2093
P356
P1433
P1476
Change in lung tumor volume as ...... ritical review of the evidence
@en
P2093
P304
P356
10.1093/ANNONC/MDQ051
P577
2010-03-23T00:00:00Z